Hinge Health, Inc. filed a Form S-1 registration statement for an initial public offering on 2025-03-10. It has amended it 4 times. It filed its final prospectus on 2025-05-23, at a public offering price of $32.00 per share. Each fact below is quoted from the filing named with it.
What the filings say
Listing
We have been approved to list our Class A common stock on the New York Stock Exchange under the symbol HNGE.From the 424B4 filed 2025-05-23
Offering price
The initial public offering price per share of our Class A common stock is $32.00.From the 424B4 filed 2025-05-23
Revenue
Our revenue was $390.4 million and $292.7 million for the years ended December 31, 2024 and 2023, respectively, representing a year-over-year growth rate of 33%, and our revenue was $123.8 million and $82.7 million for the three months ended March 31, 2025 and 2024, respectively, representing a year-over-year growth rate of 50%.From the S-1/A filed 2025-05-16
Net loss or income
We incurred a net loss of $11.9 million and $108.1 million for the years ended December 31, 2024 and 2023, respectively, and we had net income of $17.1 million and incurred a net loss of $26.5 million for the three months ended March 31, 2025 and 2024, respectively.From the S-1/A filed 2025-05-16
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2025-03-10 | Registration statement filed | S-1 |
| 2025-04-07 | Registration statement amended | S-1/A |
| 2025-05-05 | Registration statement amended | S-1/A |
| 2025-05-13 | Registration statement amended | S-1/A |
| 2025-05-16 | Registration statement amended | S-1/A |
| 2025-05-23 | Final prospectus filed: the offering is priced | 424B4 |
Tools for this story
Each opens in a new tab, filled in for Hinge Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.